Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Immatics N.V. - Ordinary Shares
(NQ:
IMTX
)
9.590
+0.190 (+2.02%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 17, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immatics N.V. - Ordinary Shares
< Previous
1
2
3
4
Next >
Immatics Announces Proposed $150 Million Public Offering
October 10, 2024
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces Updated Phase 1b Clinical Data on ACTengine® IMA203 TCR-T Targeting PRAME in Melanoma Patients and Provides Update on Upcoming SUPRAME Phase 3 Trial
October 10, 2024
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces Upcoming Oral and Poster Presentations at the Society for Immunotherapy of Cancer Annual Meeting 2024
October 04, 2024
From
https://immatics.com/
Via
GlobeNewswire
Why Immatics Shares Are Rising Today
↗
July 24, 2023
Immatics N.V. (NASDAQ: IMTX) shares are trading higher after the company announced
Via
Benzinga
Recap: Immatics Q1 Earnings
↗
May 16, 2023
Via
Benzinga
Biotech Stocks : Are You A Trader Or A Longer Term Investor?
↗
October 01, 2024
Biotech bull market is intact as indicated by large cap biopharma and the best performing funds.
Via
Talk Markets
Immatics Presents Clinical Proof-of-Concept Data from Ongoing Phase 1 Dose Escalation Trial with TCR Bispecific Molecule TCER® IMA401 Targeting MAGEA4/8 at ESMO 2024 and Provides Development Update
September 16, 2024
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces Upcoming Oral Presentation at the Society for Melanoma Research Congress 2024
September 06, 2024
From
https://immatics.com/
Via
GlobeNewswire
IMTX Stock Earnings: Immatics Beats EPS, Beats Revenue for Q2 2024
↗
August 13, 2024
IMTX stock results show that Immatics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Immatics Announces Second Quarter 2024 Financial Results and Business Update
August 13, 2024
From
https://immatics.com/
Via
GlobeNewswire
Immatics Appoints Alise Reicin to Board of Directors
July 31, 2024
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces Upcoming Oral Presentation at ESMO Congress 2024
July 18, 2024
From
https://immatics.com/
Via
GlobeNewswire
Trading SMID Biotech Stocks In A Volatile Market
↗
July 01, 2024
Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a...
Via
Talk Markets
12 Health Care Stocks Moving In Friday's Intraday Session
↗
May 24, 2024
Via
Benzinga
Immatics Announces First Quarter 2024 Financial Results and Business Update
May 14, 2024
From
https://immatics.com/
Via
GlobeNewswire
IMTX Stock Earnings: Immatics Beats EPS, Beats Revenue for Q4 2023
↗
March 21, 2024
IMTX stock results show that Immatics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
March 21, 2024
Via
Benzinga
Immatics Announces Full Year 2023 Financial Results and Corporate Update
March 21, 2024
From
https://immatics.com/
Via
GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
↗
March 18, 2024
Via
Benzinga
Immatics Announces Pricing of $175 Million Public Offering
January 17, 2024
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces Proposed Public Offering
January 17, 2024
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces Third Quarter 2023 Financial Results and Business Update
November 14, 2023
From
https://immatics.com/
Via
GlobeNewswire
Immatics Reports Interim Clinical Data from ACTengine® IMA203 and IMA203CD8 TCR-T Monotherapies Targeting PRAME in an Ongoing Phase 1 Trial
November 08, 2023
From
https://immatics.com/
Via
GlobeNewswire
Immatics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ACTengine® IMA203 TCR-T Monotherapy
October 24, 2023
From
https://immatics.com/
Via
GlobeNewswire
Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics
September 11, 2023
Via
ACCESSWIRE
Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics
September 11, 2023
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces Second Quarter 2023 Financial Results and Business Update
August 17, 2023
From
https://immatics.com/
Via
GlobeNewswire
Immatics Initiates Phase 1/2 Clinical Trial to Evaluate PRAME TCR Bispecific IMA402 in Patients with Advanced Solid Tumors
August 10, 2023
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces $35 Million Equity Investment from Bristol Myers Squibb
July 24, 2023
From
https://immatics.com/
Via
GlobeNewswire
Top 5 Health Care Stocks That May Crash This Month
↗
June 22, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
